What type of insulin is insulatard?

02/07/2020 Off By admin

What type of insulin is insulatard?

Insulatard® is an isophane (NPH) human insulin suspension. Each ml contains 100 IU of human insulin.

What is insulatard for?

Insulatard is a suspension for injection that contains the active substance human insulin. It is available as vials, cartridges (Penfill), or pre-filled pens (InnoLet or FlexPen). What is Insulatard used for? Insulatard is used to treat diabetes. The medicine can only be obtained with a prescription.

What pen do you use for insulatard?

Insulatard suspension for injection in pre-filled pen: Your FlexPen is a unique dial-a-dose insulin pen. You can select doses from 1 to 60 units in increments of 1 unit. FlexPen is designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.

How do you use vial insulatard?

To inject Insulatard on its own

  1. Just before injecting this insulin, roll the vial between your hands until the liquid is uniformly white and cloudy.
  2. Draw air into the syringe, in the same amount as the dose of insulin you need.
  3. Inject the air into the vial: push the needle through the rubber stopper and press the plunger.

Where do you inject insulatard?

Insulatard is a human insulin with gradual onset and long duration of action. Insulatard is administered subcutaneously by injection in the thigh, the abdominal wall, the gluteal region or the deltoid region.

When do you administer insulatard?

Insulatard is a long-acting insulin. It can be given once or twice a day, with or without a fast-acting insulin (given at meal times), according to the doctor’s recommendation. The usual dose is between 0.3 and 1.0 international units (IU) per kilogram body weight per day.

How do you administer insulatard?

Insulatard is administered subcutaneously by injection in the thigh, the abdominal wall, the gluteal region or the deltoid region. Injection sites should always be rotated within the same region in order to reduce the risk of lipodystrophy and cutaneous amyloidosis (see sections 4.4 and 4.8).